Adam M. Acosta
Adam Acosta's practice focuses on antitrust litigation, government investigations, and related counseling. He represents clients in a wide range of industries and frequently works on pharmaceutical antitrust matters. Mr. Acosta has successfully helped clients defeat a motion for class certification in a reverse payment case, secure summary judgment against product hopping claims, and obtain a defense verdict in a price-fixing trial.
Pro bono is also an important part of Mr. Acosta's practice. He recently helped a client obtain executive clemency, significantly reducing a non-violent drug offender's excessive federal sentence. Mr. Acosta also focuses on tenant rights and related housing litigation.
Prior to joining White & Case, Mr. Acosta completed a two-year clerkship in the U.S. District Court for the Southern District of Indiana. He currently serves as a board member for the Hispanic Bar Association of D.C. and is active in the ABA's Antitrust Section.
FTC Publishes Annual MMA Report and Updated Filing Procedures, Client Alert, 2019 (co-author)
United States: Pharmaceutical Antitrust, Global Competition Review (co-author) (updated annually from 2015-2019)
Hospital-Merger Litigation in 2014 Leads to Divestitures, Trying Antitrust, ABA Trial Practice Committee, 2015
Predictive Coding: The Beginning of a New E-Discovery Era, 56 RES GESTAE 8, 2012, republished with updates at 30 COMP. & INTERNET LAW. J. 26, 2013
Len Bias' Death Still Haunts Crack-Cocaine Offenders After Twenty Years: Failing to Reduce Disproportionate Crack-Cocaine Sentences Under 18 U.S.C. § 3582, 53 HOW. L.J. 825, 2010
On the Rise: Top 40 Young Lawyers, American Bar Association, 2019
Best Antitrust Business Article – Intellectual Property Category, Concurrences Antitrust Writing Awards, 2018
Associate Leadership Institute Fellow, New York City Bar, 2018
Bench Bar Scholar, Indianapolis Bar Association, 2012
Corporate Scholar, Association of Corporate Counsel, National Capital Region, 2010